Cargando…

A38 Diversity analyses of HIV-1 envelope glycoproteins in HIV-infected individuals with and without broadly neutralizing antibodies

Detalles Bibliográficos
Autores principales:	Mabvakure, B., Scheepers, C., Nonyane, M., Lambson, B., Madzorera, S., Kitchin, D., Bhiman, J., Wibmer, K., Abdool Karim, S., Williamson, C., Morris, L., Moore, P.L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstract Overview
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565991/ https://www.ncbi.nlm.nih.gov/pubmed/28845277 http://dx.doi.org/10.1093/ve/vew036.037

Ejemplares similares

A1 The role of virus-antibody co-evolution in the development of a V3-glycan-directed HIV-1 broadly neutralizing antibody lineage
por: Kitchin, D, et al.
Publicado: (2019)

Positive Selection at Key Residues in the HIV Envelope Distinguishes Broad and Strain-Specific Plasma Neutralizing Antibodies
por: Mabvakure, Batsirai M., et al.
Publicado: (2019)

Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models
por: Lacerda, Miguel, et al.
Publicado: (2013)

Dependence on a variable residue limits the breadth of an HIV MPER neutralizing antibody, despite convergent evolution with broadly neutralizing antibodies
por: Scheepers, Cathrine, et al.
Publicado: (2022)

Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization Escape
por: Scheepers, Cathrine, et al.
Publicado: (2020)

P09-04. Charge changes in the alpha2-helix in the C3 region of the HIV-1 subtype C envelope mediate neutralization escape
por: Moore, PL, et al.
Publicado: (2009)

V2-Directed Vaccine-like Antibodies from HIV-1 Infection Identify an Additional K169-Binding Light Chain Motif with Broad ADCC Activity
por: van Eeden, Charmaine, et al.
Publicado: (2018)

Photosensitive disorders in HIV
por: Koch, Karen
Publicado: (2017)

Genetic Signatures in the Envelope Glycoproteins of HIV-1 that Associate with Broadly Neutralizing Antibodies
por: Gnanakaran, S., et al.
Publicado: (2010)

Viral Escape from HIV-1 Neutralizing Antibodies Drives Increased Plasma Neutralization Breadth through Sequential Recognition of Multiple Epitopes and Immunotypes
por: Wibmer, Constantinos Kurt, et al.
Publicado: (2013)

An overview of tenofovir and renal disease for the HIV-treating clinician
por: Venter, Willem D.F., et al.
Publicado: (2018)

Rapid and Focused Maturation of a VRC01-Class HIV Broadly Neutralizing Antibody Lineage Involves Both Binding and Accommodation of the N276-Glycan
por: Umotoy, Jeffrey, et al.
Publicado: (2019)

New law on HIV testing in Botswana: The implications for healthcare professionals
por: Sarumi, Rofiah O., et al.
Publicado: (2015)

AAV-Mediated Expression of Broadly Neutralizing and Vaccine-like Antibodies Targeting the HIV-1 Envelope V2 Region
por: van den Berg, Fiona T., et al.
Publicado: (2019)

Approach to acute kidney injury in HIV-infected patients in South Africa
por: Boswell, Michael T., et al.
Publicado: (2017)

IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody
por: Richardson, Simone I., et al.
Publicado: (2019)

HIV Superinfection Drives De Novo Antibody Responses and Not Neutralization Breadth
por: Sheward, Daniel J., et al.
Publicado: (2018)

Replication of influential studies on biomedical, social, behavioural and structural interventions for HIV prevention and treatment
por: Djimeu, Eric W., et al.
Publicado: (2020)

Burden of typhoid fever and cholera: similarities and differences. Prevention strategies for European travelers to endemic/epidemic areas
por: AMICIZIA, D., et al.
Publicado: (2019)

Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies
por: Bhiman, Jinal N., et al.
Publicado: (2015)

Conformational flexibility of HIV-1 envelope glycoproteins modulates transmitted / founder sensitivity to broadly neutralizing antibodies
por: Ratnapriya, Sneha, et al.
Publicado: (2023)

Mechanistic Analysis of the Broad Antiretroviral Resistance Conferred by HIV-1 Envelope Glycoprotein Mutations
por: Hikichi, Yuta, et al.
Publicado: (2021)

The DREAMS core package of interventions: A comprehensive approach to preventing HIV among adolescent girls and young women
por: Saul, Janet, et al.
Publicado: (2018)

Baseline and time‐updated factors in preclinical development of anionic dendrimers as successful anti‐HIV‐1 vaginal microbicides
por: Rodríguez‐Izquierdo, Ignacio, et al.
Publicado: (2022)

Pre-Exposure Prophylaxis for the Prevention of HIV Infection in High Risk Populations: A Meta-Analysis of Randomized Controlled Trials
por: Jiang, Junjun, et al.
Publicado: (2014)

Feasible, Efficient and Necessary, without Exception – Working with Sex Workers Interrupts HIV/STI Transmission and Brings Treatment to Many in Need
por: Steen, Richard, et al.
Publicado: (2015)

Voluntary Medical Male Circumcision for HIV Prevention: New Mathematical Models for Strategic Demand Creation Prioritizing Subpopulations by Age and Geography
por: Hankins, Catherine, et al.
Publicado: (2016)

Re-organisation of the management of patients affected with chronic pathologies in Lombardy Region: critical points associated with the management of HIV positive patients
por: RESTELLI, U., et al.
Publicado: (2018)

Temsavir Treatment of HIV-1-Infected Cells Decreases Envelope Glycoprotein Recognition by Broadly Neutralizing Antibodies
por: Boutin, Marianne, et al.
Publicado: (2022)

HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies
por: Richardson, Simone I., et al.
Publicado: (2018)

A broad HIV-1 inhibitor blocks envelope glycoprotein transitions critical for entry
por: Herschhorn, Alon, et al.
Publicado: (2014)

A26 Probing the compartmentalization of HIV-1 in the central nervous system through its neutralization properties
por: Stefic, K, et al.
Publicado: (2018)

A20 The search for replication-competent HIV during effective therapy
por: Hiener, B., et al.
Publicado: (2017)

A13 HIV drug resistance over a decade of antiretroviral therapy scale-up for HIV/AIDS patients in Vietnam
por: Nguyen, L.A., et al.
Publicado: (2017)

A13 HIV drug resistance over a decade of antiretroviral therapy scale-up for HIV/AIDS patients in Vietnam
por: Nguyen, L.A., et al.
Publicado: (2017)

V5 region in the HIV-1 envelope glycoprotein determines viral sensitivity to the broadly neutralizing monoclonal antibody VRC01
por: Guo, D, et al.
Publicado: (2012)

A3 Molecular epidemiology of HIV-1 in Nigeria
por: Nazziwa, J, et al.
Publicado: (2019)

A5 Peripheral blood cells contribute to HIV-1 viremia induced by romidepsin
por: Winckelmann, A., et al.
Publicado: (2017)

Strategies for induction of HIV‐1 envelope‐reactive broadly neutralizing antibodies
por: Williams, Wilton B., et al.
Publicado: (2021)

A28 Phylogeographic analysis of HIV-2 ANRS CO5 cohort reveals new trends in HIV-2 epidemic patterns in West Africa
por: Visseaux, B, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qusljd6ffehvb41ft686jl3d3k